Phase II study of perioperative mFOLFOX plus Panitumumab for stage III rectal cancer
Not Applicable
Recruiting
- Conditions
- rectal cancer
- Registration Number
- JPRN-UMIN000006039
- Lead Sponsor
- Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 43
Inclusion Criteria
Not provided
Exclusion Criteria
Previous treatment of rectal cancer Multiple cancer and/or double cancer Any severe concurrent medical condition which would make it undesirable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method